Monday June 22, 7:01 am Eastern Time
Company Press Release
SOURCE: BCAM International, Inc.
BCAM International, Inc., on Behalf of Its Subsidiary, ISTX, Inc. Names Peter Cavanagh to Head Tech Advisory Board
Leading Authority on the Foot and Its Function in Locomotion
MELVILLE, N.Y., June 22 /PRNewswire/ -- BCAM International, Inc. (Nasdaq: BCAM - news), developer of revolutionary patented intelligent surface and microvalve technology that allows surfaces in seating, footwear, mattresses and most products touching the body to automatically conform to the body for utmost in comfort and fit, announced today that it's subsidiary, ISTX, Inc. has established a Technology Advisory Board and named Peter R. Cavanagh, Distinguished Professor of Locomotion Studies, Biobehavioral Health, Orthopaedics and Rehabilitation, and Medicine, of The Pennsylvania State University as head of this advisory board.
Michael Strauss, Chairman and Chief Executive Officer of BCAM International said, ''We are gratified that Dr. Cavanagh, one of the nation's most eminent authorities on the mechanics of the foot and its function in locomotion, has agreed to head our Technology Advisory Board. A leading clinical researcher, Dr. Cavanagh has advised most of the major footwear manufacturers in the United States, Europe and Japan on shoe design and testing. His expertise will be invaluable in the development of products that will incorporate our technology in the footcare industry and in pursuing BCAM International's strategy of consolidating the highly fragmented medical footcare industry.''
Dr. Cavanagh said ''BCAM is an exciting company, and I am very pleased to be working with BCAM and its subsidiary, ISTX, Inc. to help build a strong leading company in this important and fragmented industry.''
Dr. Cavanagh is also research director of Penn State's Diabetes Foot Clinics at University Park and at the Milton S. Hershey Medical Center, Hershey, PA. He has served as a Visiting Professor in the Department of Medicine at the University of Manchester, UK and has lectured widely in the U.S., Europe, and Asia.Currently, Dr. Cavanagh holds grants from the American Diabetes Association, and the National Institute on Aging to conduct research on foot problems associated with diabetes. He is also funded by NASA and the National Institute of Child Health and Human Development to explore issues related to osteoporosis in Space and on Earth.
In addition, he is the holder of more than a dozen honors from various professional societies and educational institutions. Dr. Cavanagh is a past President of the American Society of Biomechanics and the International Society of Biomechanics. He is currently the Chairman of the Council on Foot Care of the American Diabetes Association and is a member of the British Diabetes Association and the European Association for the Study of Diabetes.
Dr. Cavanagh has contributed over 200 articles and abstracts to the professional literature, and is the author, co-author, editor or co-editor of seven books. Among his most recent publications, is ''The Foot in Diabetes,'' published by John Wiley & Sons.BCAM International Inc., Melville, New York, specializes in the development of technology that enables surfaces to adjust themselves in real time to conform to any part of the body for utmost of comfort, fit and enhanced user performance, and also in the consolidation of the highly fragmented medical footcare industry.
This announcement contains ''forward-looking'' statements. The words, ''anticipate,'' ''believe,'' ''estimate,'' and ''expect'' and other similar expressions as they relate to the Company and its management are intended to identify such forward-looking statements. Although the Company and its management believe that the statements contained in this announcement are reasonable, it can give no assurances that such statements will prove correct. Factors that could affect the occurrence of events or results discussed herein include those mentioned in the Company's Form 10-KSB.
SOURCE: BCAM International, Inc. |
